IMMUNSUPPRESSIVE FORMULIERUNGEN

Patent europeic · EP2661261 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2661261
Numer da la dumonda
EP12700262
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-01-2012
Publitgà
13-11-2013
Concedì
31-07-2019
La protecziun finescha il pli tard
04-01-2032
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 9/20 (2006.01)
A61K 31/397 (2006.01)
Prioritad
EP 11150431 07.01.2011
Dumonda PCT
PCT/EP2012/050151 05.01.2012
Publicaziun PCT
WO2012/093161 12.07.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 31-07-2019

    Concedì

    Published in Swissreg on 31.07.2019

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

BOUILLOT, Philippe

CH-4002 Basel

REYNAUD, Emeric

CH-4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.